- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 473/10 - Heterocyclic compounds containing purine ring systems with oxygen, sulfur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
Patent holdings for IPC class C07D 473/10
Total number of patents in this class: 25
10-year publication summary
|
1
|
4
|
0
|
3
|
0
|
1
|
0
|
2
|
0
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Sun Pharmaceutical Industries Inc | 232 |
4 |
| Fertis India Pvt. Ltd. | 71 |
3 |
| Concert Pharmaceuticals, Inc. | 244 |
2 |
| West China Hospital, Sichuan University | 237 |
2 |
| Guangdong Raynovent Biotech Co., Ltd. | 53 |
2 |
| Arxada AG | 67 |
2 |
| Guangdong Zhongsheng Pharmaceutical Co., Ltd | 25 |
1 |
| Lonza Ltd. | 586 |
1 |
| Meiji Seika Kaisha, Ltd. | 46 |
1 |
| National Institute of Biological Sciences, Beijing | 101 |
1 |
| Natraceutical S.A. | 3 |
1 |
| NovaCardia, Inc. | 3 |
1 |
| The School Corporation Kansai University | 178 |
1 |
| Shin Nippon Yakugyo Co., Ltd. | 8 |
1 |
| Organoidsciences Ltd. | 30 |
1 |
| China Meheco Kangli Pharma Co., Ltd. | 6 |
1 |
| Other owners | 0 |